BIOLINERX LTD-SPONS ADR
BLRX · NASDAQ
Updated at 2026-10-15 06:51:57
- Today's High
- $2.18
- Today’s Low
- $2.01
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.18
- Previous Close
- $2.07
- Volume
- 23.53K
- Market Cap
- $35.84M
- P/E Ratio
- --
- EPS
- $0.00
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- MODI?IN TECHNOLOGY PARK, HEVEL MODI'IN, ISRAEL, 7177871
- Country
- IL
- Listing Date
- 2007-01-30
- Fiscal Year End
- December
- Shares Outstanding
- 2.62B
- CIK
- 0001498403
- Website
- www.biolinerx.com
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company is headquartered in Hevel Modi'in, Israel.
Financial Metrics
Revenue
2026-06-30
$299.04K
2026-03-31
$477K
2025-12-31
$195.21K
2025-09-30
$427K
Operating Expenses
2026-06-30
$3.79M
2026-03-31
$3.38M
2025-12-31
$3.49M
2025-09-30
$2.55M
Net Income
2026-06-30
-$3.07M
2026-03-31
-$2.58M
2025-12-31
-$1.39M
2025-09-30
-$977K
Net Profit Margin
2026-06-30
-1.02K%
2026-03-31
-541.08%
2025-12-31
-713.92%
2025-09-30
-228.8%
Earnings Per Share
2026-06-30
$-0.77
2026-03-31
$-0.58
2025-12-31
$-0.32
2025-09-30
$-0.22
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.55M
2026-03-31
-$2.25M
2025-12-31
-$1.9M
2025-09-30
-$554K
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $299.04K | $477K | $195.21K | $427K |
| Operating Expenses | $3.79M | $3.38M | $3.49M | $2.55M |
| Net Income | -$3.07M | -$2.58M | -$1.39M | -$977K |
| Net Profit Margin | -1.02K% | -541.08% | -713.92% | -228.8% |
| Earnings Per Share | $-0.77 | $-0.58 | $-0.32 | $-0.22 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.55M | -$2.25M | -$1.9M | -$554K |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.